Verified peer comparison
PharmaCyte Biotech, Inc. vs J-Long Group Limited - Class A Ordinary Shares Financial Comparison
PharmaCyte Biotech, Inc. versus J-Long Group Limited - Class A Ordinary Shares…
Direct answer
PharmaCyte Biotech, Inc. and J-Long Group Limited - Class A Ordinary Shares are compared on the same basis.
The comparison uses 2026 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free PharmaCyte Biotech, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- PharmaCyte Biotech, Inc. Revenue
- 0 USD
- J-Long Group Limited - Class A Ordinary Shares Revenue
- 5,411,089 USD
- PharmaCyte Biotech, Inc. Operating income
- -5,304,286 USD
- J-Long Group Limited - Class A Ordinary Shares Operating income
- 378,840 USD